PRKACA and neoplasm: The association of PRKACA expression with some adverse clinicopathological features of gastrointestinal cancers, such as advanced age, tumor site, tumor histotype, nodal stage, and TNM stage, are in keeping with the tumor-promoting activities in the above-mentioned studies.